← Outset Medical, Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $15.1m |
$49.9m
+231.18%
|
$102.6m
+105.47%
|
$115.4m
+12.45%
|
$130.4m
+13.00%
|
$113.7m
-12.80%
|
$119.5m
+5.09%
|
$117.8m
-1.40%
|
|
| Cost of Revenue | $32.9m |
$63.0m
+91.52%
|
$95.0m
+50.85%
|
$97.5m
+2.68%
|
$101.4m
+3.93%
|
$75.1m
-25.89%
|
$72.7m
-3.20%
|
$68.6m
-5.66%
|
|
| Gross Profit | ($17.8m) |
($13.0m)
+26.77%
|
$7.6m
+158.36%
|
$17.8m
+134.40%
|
$29.0m
+62.62%
|
$38.6m
+32.98%
|
$46.8m
+21.24%
|
$49.2m
+5.23%
|
|
| Research and Development Expense | $23.3m | $28.9m | $36.7m | $48.9m | $57.3m | $38.4m | $21.2m | $21.5m | |
| Selling and Marketing Expense | $20.3m | $45.1m | $65.1m | $89.5m | $96.2m | $70.0m | $54.4m | $93.7m | |
| General and Administrative Expense | $8.9m | $30.5m | $36.3m | $40.5m | $45.2m | $43.5m | $37.9m | $41.9m | |
| Operating Expenses | $52.5m | $104.4m | $138.1m | $178.9m | $198.8m | $151.9m | $113.5m | $115.2m | |
| Operating Income (Loss) | ($70.3m) |
($117.5m)
-67.08%
|
($130.5m)
-11.11%
|
($161.0m)
-23.37%
|
($169.8m)
-5.43%
|
($113.4m)
+33.22%
|
($66.7m)
+41.16%
|
($66.0m)
+1.00%
|
|
| Interest Expense | $4.3m | $2.9m | $1.7m | $3.6m | $12.7m | $23.9m | $14.0m | $13.7m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $68.3m | $121.5m | ($128.4m) | ($153.2m) | ($158.1m) | ($116.7m) | ($70.4m) | ($73.4m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($68.3m) | ($121.5m) | ($131.7m) | ($162.7m) | ($172.3m) | ($127.5m) | ($80.9m) | ($73.4m) | |
| Income Tax Expense (Benefit) | $20k | $0 | $199k | $295k | $523k | $491k | $718k | $936k | |
| Net Income (Loss) Attributable to Parent | ($68.3m) |
($121.5m)
-77.88%
|
($131.9m)
-8.60%
|
($163.0m)
-23.51%
|
($172.8m)
-6.04%
|
($128.0m)
+25.94%
|
($81.7m)
+36.20%
|
($74.3m)
+9.02%
|
|
| Earnings Per Share, Basic | — | — | — | ($3.38) | ($3.48) | ($2.46) | ($5.37) | ($3.80) | |
| Earnings Per Share, Diluted | — | — | — | ($3.38) | ($3.48) | ($2.46) | ($5.37) | ($3.80) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | 48k | 50k | 52k | 15k | 18.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | 48k | 50k | 52k | 15k | 18.2m | |
| Additional Financial Items | |||||||||
| Other General Expense | — | — | — | — | — | — | $0 | — |